Molecular evidence for the presence of a G7 genotype of Echinococcus granulosus in Slovakia

Variability in Echinococcus granulosus is very important epidemiologically since strain characteristics may influence local patterns of transmission of hydatid disease. To classify the genotype presented in pig protoscoleces of the Slovak territory, a DNA-based approach has been used. Nucleotide sequences for a 471 bp region of the mitochondrial NADH dehydrogenase 1 (ND1) gene revealed a substantial affinity of isolates examined to the G7 genotype. Only a 0.9-3.4% sequence variation was recorded for E. granulosus samples compared with the reference G7 variant. To distinguish between G7 and G9 genotypes not differing in ND1 sequences, isolates were additionally examined by PCR-RFLP analysis of the nuclear ITS1 region. The resulting two-banded pattern is characteristic for the G7 strain. The data presented thus provides the first explicit evidence of the G7 genotype in the Slovak region

Toxoplasma gondii in protected wildlife in the Tatra National Park (TANAP), Slovakia

[i]Toxoplasma gondii[/i] is an obligatory intracellular protozoan parasite that infects a broad spectrum of warm-blooded vertebrate species. As a part of the food chain, farm animals play a significant role in transmission of [i]T. gondii [/i]to humans, while rats and mice serve as a main source of infection for free-living animals. The spread of toxoplasmosis in the human population is due to the interchange of the domestic and sylvatic cycles. During 2009–2011, a survey on toxoplasmosis distribution was conducted in wildlife of the Tatra National Park (TANAP) in Slovakia. A total of 60 animals were examined. The presence of [i]T. gondii[/i] was detected by means of molecular methods based on TGR1E gene analyses. The highest prevalence was recorded in birds (40.0%), followed by carnivores (30.8%) and rodents (18.2%). RFLP analyses of SAG2 locus confirmed in birds the genotype II and III, belonging to the avirulent strain; rodents exclusively had genotype I, characterised as a virulent train, and in carnivores all three genotypes were detected. These results present the first survey on the parasite’s occurrence in several species of free-living animals in the TANAP area. An epidemiological study confirmed the prevalence of 30.0%, implicitly referring to the level of environmental contamination with [i]T. gondii [/i]oocysts

microRNA-29a in adult muscle stem cells controls skeletal muscle regeneration during injury and exercise downstream of fibroblast growth factor-2

The expansion of myogenic progenitors (MPs) in the adult muscle stem cell niche is critical for the regeneration of skeletal muscle. Activation of quiescent MPs depends on the dismantling of the basement membrane and increased access to growth factors such as fibroblast growth factor-2 (FGF2). Here, we demonstrate using microRNA (miRNA) profiling in mouse and human myoblasts that the capacity of FGF2 to stimulate myoblast proliferation is mediated by miR-29a. FGF2 induces miR-29a expression and inhibition of miR-29a using pharmacological or genetic deletion decreases myoblast proliferation. Next generation RNA sequencing from miR-29a knockout myoblasts (Pax7(CE/+) ; miR-29a(flox/flox) ) identified members of the basement membrane as the most abundant miR-29a targets. Using gain- and loss-of-function experiments, we confirm that miR-29a coordinately regulates Fbn1, Lamc1, Nid2, Col4a1, Hspg2 and Sparc in myoblasts in vitro and in MPs in vivo. Induction of FGF2 and miR-29a and downregulation of its target genes precedes muscle regeneration during cardiotoxin (CTX)-induced muscle injury. Importantly, MP-specific tamoxifen-induced deletion of miR-29a in adult skeletal muscle decreased the proliferation and formation of newly formed myofibers during both CTX-induced muscle injury and after a single bout of eccentric exercise. Our results identify a novel miRNA-based checkpoint of the basement membrane in the adult muscle stem cell niche. Strategies targeting miR-29a might provide useful clinical approaches to maintain muscle mass in disease states such as ageing that involve aberrant FGF2 signaling. This article is protected by copyright. All rights reserved